Open access
Open access
Powered by Google Translator Translator

ASCO 2018: Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

7 Jun, 2018 | 02:21h | UTC

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma – New England Journal of Medicine (free)

Editorial: Cytoreductive Nephrectomy — Patient Selection Is Key (free)

Commentaries: 2018 ASCO: Carmena Trial Compares Nephrectomy Plus Adjuvant Sunitinib vs Sunitinib Alone in Metastatic RCC – The ASCO Post (free) AND In Advanced Kidney Cancer, Surgery No Longer Sole Standard of Care – Medscape (free registration required)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.